Nonalcoholic Fatty Liver Disease Is Associated with Increased Atrial Fibrillation Risk in an Elderly Chinese Population: A Cross-Sectional Study
Table 2
Clinical characteristics of study participants stratified by NAFLD status.
Characteristic
Without NAFLD (n=1166)
With NAFLD (n=522)
t value
P-value
Gender (n) (male/female)
661/505
269/253
3.876
0.049
Age (years)
72 (68-77)
71 (68-75)
-3.09
0.002
Body mass index (kg/m2)
23.0±2.5
25.8±2.8
19.452
0.001
Systolic blood pressure (mmHg)
134.2±17.4
137.7±16.9
3.853
0.001
Diastolic blood pressure (mmHg)
74.0±10.1
76.1±10.3
4.046
0.001
Total cholesterol (mmol/L)
4.89±0.99
4.96±1.00
1.314
0.189
High-density lipoprotein (mmol/L)
1.7±0.4
1.5±0.3
-11.008
0.001
Low-density lipoprotein (mmol/L)
2.6±0.8
2.7±0.8
1.542
0.123
Triglycerides (mmol/L)
1.02 (0.78-1.45)
1.47 (1.10-2.04)
-13.11
0.001
Aspartate aminotransferase (U/L)
23 (20-27)
24 (20-30)
-2.93
0.003
Alanine aminotransferase (U/L)
16 (12-21)
20 (15-28)
-9.94
0.001
γ-glutamyl transpeptidase (U/L)
20 (16-29)
26 (19-37)
-9.65
0.001
Albumin (g/L)
45.3±2.7
45.8±2.7
3.400
0.001
Fasting plasma glucose (mmol/L)
5.26 (4.86-5.82)
5.52 (5.12-6.27)
-6.95
0.001
Serum uric acid (umol/L)
329±81.6
367±89.2
8.722
0.001
AF (%)
1.8
3.4
4.335a
0.037
Data are expressed as mean ± SD, median (IOQ), or percentage; a indicates χ2 test; b indicates Mann–Whitney U test. NAFLD, nonalcoholic fatty liver disease; AF, atrial fibrillation.
